A Dose-Finding Study of OPC-6535 in Patients With Active Ulcerative Colitis

Trial Profile

A Dose-Finding Study of OPC-6535 in Patients With Active Ulcerative Colitis

Completed
Phase of Trial: Phase II

Latest Information Update: 19 May 2016

At a glance

  • Drugs Tetomilast (Primary) ; Mesalazine
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Sponsors Otsuka Pharmaceutical
  • Most Recent Events

    • 12 May 2014 New trial record
    • 12 Oct 2007
    • 20 Sep 2006
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top